Extrapyramidal and Other Neurologic Manifestations Associated with Carbon Disulfide Fumigant Exposure
Arch Neurol 45:537-540, Peters,H.A.,et al, 1988
Treatment of Dopaminomimetic Psychosis in Parkinson's Disease with Electroconvulsive Therapy
Can J Neurol Sci 15:32-34, Hurwitz,T.A.&Waterman,C., 1988
Hallervorden-Spatz Syndrome:Clinical and Magnetic Resonance Imaging Correlations
Ann Neurol 24:692-694, Sethi,K.D.,et al, 1988
Diffuse Lewy Body Disease and Progressive Dementia
Neurol 38:1520-1528, Burkhardt,C.R.,et al, 1988
Hand Contractures in Parkinson's Disease
JNNP 51:1221-1223, Kyriakides,T.&Hewer,R.L., 1988
PHNO[ (+) -4-Propyl-9-Hydroxynaphthoxazine]:A New and Effective Anti-Parkinson's Disease Agent
Neurol 38:1541-1545, Muenter,M.D.,et al, 1988
Risk Factors for Progression in Parkinson's Disease
Neurol 38:1841-1844, Goetz,C.G.,et al, 1988
Role of Subcutaneous Apomorphine in Parkinsonian Voiding Dysfunction
Lancet 2:1451-1453, Christmas,T.J.,et al, 1988
Dementia and Cognitive Impairment in Parkinson's Disease
JNNP 51:1498-1502, Girotti,F.,et al, 1988
Parkinsonism Death Rates by Race, Sex, and Geography
Neurol 38:1558-1561, Kurtzke,J.F.&Goldberg,I.D., 1988
Amitriptyline in the Treatment of Headache in Patients with Parkinson's Disease:Double-Blind Study
Neurol 38:1720-1721, Indaco,A.&Carrieri,P.B., 1988
Dystonic-Parkinsonian Syndrome after Cyanide Poisoning:Clinical and MRI Findings
JNNP 51:1345-1348, Carella,F.,et al, 1988
A Creutzfeldt-Jakob Like Syndrome Due to Lithium Toxicity
JNNP 51:120-123, Smith,S.J.M.&Kocen,R.S., 1988
Creutzfeldt-Jakob Disease without Periodic Sharp Wave Complexes:A Clinical, EEG, and Path Study
Neurol 38:1056-1060, Zochodne,D.W.,et al, 1988
Observations on the Applicability of the Wartenberg Pendulum Test to Healthy, Elderly Subjects
JNNP 51:1171-1177, Brown,R.A.,et al, 1988
Pathophysiology & Clinical Assessment of Motor Symptoms in Parkinson's Disease
In Handbk of Parkinson's Disease, Marcel Dekker, Inc, New York, p997., Jankovic,J., 1987
Classification of Parkinsonism
in Handbook of Parkinson's Disease, Marcel Dekker, Inc, New York, Ch 3, p 61., Koller,W.C., 1987
Neurological Clues from Environmental Neurotoxins
BMJ 295:346-347, Martyn,C.N., 1987
Reaction Times & Attention in Parkinson's Disease
JNNP 50:1178-1183, Bloxham,C.A.,et al, 1987
Factors that Influence the Occurrence of Response Variations in Parkinson's Disease
Ann Neurol 22:4-7, deJong,G.J.,et al, 1987
Multi-Center Study of Parkinson Mortality with Early Versus Later Dopa Treatment
Ann Neurol 22:8-12, Diamond,S.G.,et al, 1987
Adjuvant Therapy of Parkinsonian Tremor
Arch Neurol 44:921-923, Koller,W.C.&Herbster,G., 1987
Neuropsychological Disturbances in Hemiparkinson's Disease
Neurol 37:1762-1764, Starkstein,S.,et al, 1987
Parkinson's Disease:Sensory & Motor Problems in Arms & Hands
Neurol 37:951-956, Schneider,J.S.,et al, 1987
Early Combination of Bromocriptine & Levodopa in the Treatment of Parkinson's Disease:A 5-Year Follow-up
Neurol 37:826-828, Rinne,U.K., 1987
Bromocriptine Induced Impotence in Parkinson's Disease
BMJ 295:367-368, Cleves,L., 1987
Forms of Dystonia in Patients with Parkinson's Disease
Neurol 37:1009-1011, Kidron,D.&Melamed,E., 1987
Clinical & Biochemical Correlates of Bradyphrenia in Parkinson's Disease
Neurol 37:1130-1134, Mayeux,R.,et al, 1987
Neuropathologic & Clinical Features of Parkinson's Disease in Alzheimer's Disease Patients
Neurol 37:754-760, Ditter,S.M.&Mirra,S.S., 1987
Pleuropulmonary & Retroperitoneal Fibrosis Associated with Bromocriptine Treatment
JNNP 50:1706-1707, Ward,C.D.,et al, 1987
The Aetiology of Mirror Writing:A New Hypothesis
JNNP 50:1572-1578, Tashiro,K.,et al, 1987
Caffeine & Tremor
Neurol 37:169-172, Koller,W.,et al, 1987
Progressive Supranuclear Palsy & a Multi-Infarct State
Neurol 37:570-576, Dubinsky,R.M.&Jankovic,J., 1987
Neurologic Aspects of Boxing
Arch Neurol 44:453-459, Jordan,B.D., 1987
Movement Disorders & AIDS
Neurol 37:37-41, Nath,A.,et al, 1987
Calcium Channels & Calcium Channel Antagonists
Ann Neurol 21:317-330, Greenberg,D.A., 1987
A Case of Normal Pressure Hydrocephalus Presenting as Levodopa Responsive Parkinsonism
JNNP 50:234, Clough,C.G., 1987
Progression of Parkinson's Disease Without Levodopa
Neurol 37:695-698, Coetz,C.G.,et al, 1987
Juvenile Parkinsonism:Clinical & Metabolic Characteristics
JNNP 50:345-348, Lima,B.,et al, 1987
Parkinson's Disease & Dementia:Norepinephrine & Dopamine in Locus Ceruleus
Neurol 37:42-46, Cash,R.,et al, 1987
Open Microsurgical Autograft of Adrenal Medulla to Caudate Nucleus in Two Pts with Intrac Parkinson's Dis
NEJM 316:831-834, 872-8731987., Madrazo,I.,et al, 1987
Update on Parkinson Disease
NY State J Med, 87:147-1531987., Lieberman,A.N., 1987
A Case-Control Study of Smoking Habits, Dementia, & Other Illnesses in Idiopathic Parkinson's Disease
Neurol 37:226-232, Rajput,A.H.,et al, 1987
Postprandial & Orthostatic Hypotension in Parkinson's Disease
Neurol 37:386-393, Micieli,G.,et al, 1987
Spatial Disorientation as an Early Symptom of Parkinson's Disease
Neurol 37:485-487, Hovestadt,A.,et al, 1987
Akathisia in Idiopathic Parkinson's Disease
Neurol 37:477-481, Lang,A.E.&Johnson,K., 1987
Controlled-Release Levodopa/Carbidopa. I. Sinemet CR3 Treatment of Response Fluctuations in Parkinson's Disease
Neurol 37:233-241, Cedarbaum,J.M.,et al, 1987
Controlled Release Levodopa Treatment of Motor Fluctuations in Parkinson's Disease
JNNP 50:194-198, Juncos,J.L.,et al, 1987
Influence of Dietary Protein on Motor Fluctuations in Parkinson's Disease
Arch Neurol 44:270-272, Pincus,J.H.&Barry,K., 1987
Disorders of the Autonomic Nervous System:Part 1. Pathophysiology & Clinical Features
Ann Neurol 21:419-430, McLeod,J.G.&Tuck,R.R., 1987